蛋白激酶B抗体
AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alp
阶段特异性胚胎表面抗原-1抗体
Fut4; SSEA-1; 3-FAL; Alpha (1,3) fucosyltransferase; Alpha 13 fucosyltransferase FucT; EC 2.4.1.; ELAM 1 ligand fucosyltransferase; ELAM ligand fucosyltransferase; ELAM1 ligand fucosyltransferase; ELF
EDEM3蛋白抗体
C1orf22; EDEM 3; edem3; EDEM3_HUMAN; ER degradation enhancer, mannosidase alpha like 3; ER degradation enhancing alpha mannosidase like 3; ER degradation enhancing alpha mannosidase like 3; ER
组蛋白1 H2BB抗体
H2B 1; H2B f; H2B histone family member F; H2B.1; H2B/f; H2BFF; Hist1h2bb; Histone 1 H2bb; Histone 1, H2bb; Histone cluster 1 H2bb; Histone H2B type 1 B; Histone H2B.1; Histone H2B.f.
Anti-BCL2L15 Polyclonal Antibody
Anti-BCL2L15 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human